On this page

Anthrasil

Anthrax Immune Globulin Intravenous (Human)

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Anthrasil

Proper name

Anthrax Immune Globulin Intravenous (Human)

Licence type

351(a)

BLA number

125562

Applicant

Emergent BioSolutions Canada Inc.

Center

CBER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
>=60 U	Injection	Intravenous	Single-Dose Vial	Rx	March 24, 2015

Source: Purple Book

Kind	Expires
Orphan exclusivity	March 24, 2022

Purple Book	FDA	Licence type, presentations, reference product, exclusivity